These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10487725)

  • 21. Somatotrophic diabetes: insulin release responses to arginine and glucagon in dogs.
    Campbell J; Pierluissi J; Green GR
    Diabetologia; 1978 Sep; 15(3):205-12. PubMed ID: 700282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.
    Wasserman DH; Lickley HL; Vranic M
    J Clin Invest; 1984 Oct; 74(4):1404-13. PubMed ID: 6148356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of selective insulin or glucagon deficiency on glucose turnover.
    Lickley HL; Ross GG; Vranic M
    Am J Physiol; 1979 Mar; 236(3):E255-62. PubMed ID: 426056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressive effect of long term sulfonylurea treatment on A, B, and D cells of normal rat pancreas.
    Filipponi P; Marcelli M; Nicoletti I; Pacifici R; Santeusanio F; Brunetti P
    Endocrinology; 1983 Dec; 113(6):1972-9. PubMed ID: 6139273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of exercise training on insulin and glucagon release from perfused rat pancreas.
    Shima K; Hirota M; Sato M; Iwami T; Oshima I
    Horm Metab Res; 1987 Sep; 19(9):395-9. PubMed ID: 3319858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of insulin and glucagon in the plasma aminoacid imbalance of chronic hepatic encephalopathy.
    Marchesini G; Zoli M; Forlani G
    Z Gastroenterol; 1979 Jul; 17(7):469-76. PubMed ID: 382661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of somatostatin inhibition of insulin and glucagon secretion.
    Bhathena SJ; Perrino PV; Voyles NR; Smith SS; Wilkins SD; Coy DH; Schally AV; Recant L
    Diabetes; 1976 Nov; 25(11):1031-40. PubMed ID: 992224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretion of immunoreactive insulin and glucagon in hamsters bearing a transplantable insuloma.
    Dunbar JC; Walsh MF; Foa PP
    Diabete Metab; 1976 Dec; 2(4):165-9. PubMed ID: 190057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory action of somatostatin on pancreatic alpha and beta cell function.
    Leblanc H; Anderson JR; Sigel MB; Yen SS
    J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine.
    Luyckx AS; Mendoza E; Lefebvre PJ
    Diabetologia; 1981 Oct; 21(4):376-82. PubMed ID: 7026333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T; Ohneda A; Nihei J; Kobayashi T
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma glucagon and insulin in rat pregnancy. Roles in glucose homeostasis.
    Saudek CD; Finkowski M; Knopp RH
    J Clin Invest; 1975 Jan; 55(1):180-7. PubMed ID: 1109177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas.
    Pederson RA; Brown JC
    Endocrinology; 1978 Aug; 103(2):610-5. PubMed ID: 744105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa.
    Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G
    Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon response to arginine after treatment of diabetes mellitus.
    Ohneda A; Ishii S; Horigome K; Yamagata S
    Diabetes; 1975 Sep; 24(9):811-9. PubMed ID: 1158041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
    Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
    Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
    Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
    J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoreactive glucagon responses to oral glucose, insulin infusion and deprivation, and somatostatin in pancreatectomized man.
    Werner PL; Palmer JP
    Diabetes; 1978 Oct; 27(10):1005-12. PubMed ID: 700256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro and in vivo effect of gold thioglucose on the insulin- and glucagon-secretion of the isolated perfused rat pancreas].
    Blech W; Bierwolf B; Weiss I; Ziegler M
    Biomed Biochim Acta; 1986; 45(4):507-22. PubMed ID: 3085662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased IGF-I bioavailability after ethanol abuse in alcoholics: partial restitution after short-term abstinence.
    Röjdmark S; Brismar K
    J Endocrinol Invest; 2001; 24(7):476-82. PubMed ID: 11508780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.